Tracking down genetic influences on brain disorders
Researchers have presented a systematic catalogue of specific variable locations in the genome that influence gene activity in the human hippocampus...
List view / Grid view
News
fMRI-neurofeedback shows promise in treating tinnitus
By using functional MRI researchers have found that neurofeedback training has the potential to reduce the severity of tinnitus or even eliminate it...
CXCL5 protein found to stimulate tumour growth in prostate cancer
Researchers identify a pathway that causes tumour acceleration in metastatic prostate cancer cells...
RT-QuIC testing detects prion protein in the skin of CJD patients
Scientists have detected abnormal prion protein in the skin of patients that have died from Creutzfeldt-Jakob disease...
SBP scientists uncover mechanism for blood vessel regeneration
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) has identified a signalling pathway that is essential for angiogenesis, the growth of new blood vessels from pre-existing vessels.
Study reveals new mechanisms of cell death in neurodegenerative disorders
Researchers have discovered new mechanisms of cell death, which may be involved in debilitating neurodegenerative disorders...
Budget 2017: Reaction from the UK’s pharmaceutical industry
The Chief Executive of the Association of the British Pharmaceutical Industry (ABPI), Mike Thompson has responded to today's Budget announcement...
Tumour environment found to trigger cells to metastasize
The environment surrounding a tumour can trigger metastatic behaviour in cancer cells...
Alzheimer’s Tau protein forms toxic complexes with cell membranes
Researchers identify the sequence and structural factors that drive Tau interaction with membranes...
GDF11 protein found to inactivate triple-negative breast cancer cells
Researchers detail a possible way to re-engage a tumour suppressor protein, that has been found to be inactivated in triple-negative breast cancer cells...
AFM-CRISPR technique used to map DNA mutations
Nanomapping technology may transform the way disease-causing genetic mutations are diagnosed and discovered...
EMA to relocate to Amsterdam, the Netherlands
The EMA will relocate to Amsterdam in the Netherlands. The Agency now has just over 16 months to prepare for the move and take up its operations in Amsterdam on 30 March 2019 at the latest...
Pre-diabetes discovery marks step towards precision medicine
Researchers have identified three specific molecules that accurately indicate insulin resistance - a major predictor of diabetes...
Reducing TIA1 improves nerve cell health in Alzheimer’s disease
Researchers have described a unique model for the biology of Alzheimer's disease which may lead to an entirely novel approach for treating the disease...
An interview with Bjorg K. Hunter, Device Engineering Manager from GSK ahead of Pre-Filled Syringes Europe 2018
A debate on the impact of PFS regulation at Pre-Filled Syringes 2018...
